YO39523 GOG 3015: A Phase III, Multicenter, Randomized, Study of Atezolizumab Versus Placebo Administered in Combination With Paclitaxel, Carboplatin, and Bevacizumab to Patients With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

February 19, 2019
Cancer - Gynecologic/ Ovarian
Principal Investigator: Rabbie K Hanna, MD
Cancer, Ovarian Cancer, ovarian, Phase 3, Phase III, Peritoneal neoplasms, fallopian tube cancer, GOG, GOG 3015